Inspire Medical Systems, Inc. (INSP) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Inspire Medical Systems, Inc. · Health Care · ref. ETF XLV · 88 calls · price $68.86
What the company does: Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
📈 Inspire Medical Systems, Inc. (INSP) stock price
$68.86-12.7% over range
Oct 14, 25low $40.05 · high $143.99Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 12 analysts
📊 JPI status :
Inspire Medical Systems, Inc. is part of our 2026 selection (JPI Fair), bought at the start of the year and tracked live. It no longer shows in today's ranking: its target has been reached, there is no gap left. See the 2026 selection and its performance →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 INSP price target & analyst consensus — price $68.86
The price target · all analysts combined (12 targets)
Highest target · 1 firm of 12$97+40.9%
Median target · of 12 targets$63.5-7.8%
Lowest target · 1 firm of 12$54-21.6%
Current price$68.86
Where these 12 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
433%
$75 ↔ $97
Below
867%
$54 ↔ $65
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 12 ratings (last 6 months)
Strong Buy00%
Buy433%
Hold758%
Sell18%
Strong Sell00%
Go deeper on the analysts
🎯 INSP price target all
All 13 calls, one by one, with our verdict on each firm.
→ See all 13 targets, analyst by analyst💡 The best analysts on INSP most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in INSP? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Inspire Medical Systems, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on INSP
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Guggenheim ↗ | 100% | +132.4% | 2 |
| SVB Leerink | 78% | +39.0% | 9 |
| Wells Fargo ↗ | 75% | +79.7% | 8 |
| Stifel ↗ | 71% | +74.5% | 7 |
| Goldman Sachs ↗ | 50% | +22.9% | 2 |
| Piper Sandler ↗ | 44% | +9.6% | 18 |
| JP Morgan ↗ | 40% | -3.1% | 5 |
| B of A Securities ↗ | 33% | +38.9% | 3 |
| Truist Securities ↗ | 18% | -14.4% | 17 |
| Mizuho ↗ | 17% | -9.4% | 6 |
See the other 7 firms
| RBC Capital ↗ | 0% | -52.7% | 6 |
| Morgan Stanley ↗ | 0% | -45.5% | 5 |
| Keybanc ↗ | 0% | -40.7% | 9 |
| Lake Street | 0% | -36.1% | 2 |
| Evercore ISI Group ↗ | 0% | -24.2% | 2 |
| UBS ↗ | 0% | -14.5% | 4 |
| Baird ↗ | 17% | -36.6% | 6 |
📊 What $1,000 invested in Inspire Medical Systems, Inc. would be worth › open the full page
In short — $1,000 invested in Inspire Medical Systems, Inc. 10 years ago would be worth $2,009 today, i.e. +9%/yr on average. Best year: 2020 (+155%), worst: 2025 (-54%). Price performance, excluding dividends.
If I'd invested $1,000 in Inspire Medical Systems, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $247 | -75% |
| 3 years ago | $195 | -80% |
| 5 years ago | $261 | -74% |
Return by year (Inspire Medical Systems, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -47% | $533 (-47%) |
| 2025 | -54% | $247 (-75%) |
| 2024 | -2% | $242 (-76%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Inspire Medical Systems, Inc.
Loading news…
📋 All analyst calls on INSP
Filtered on — · ✕ show all
▼ Underweight · 🎯$65
Price at call : $67.45 — upside -4%
Today : $68.86 — upside -6%
🎯 on INSP : no call matured yet · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
Freedom Capital Markets
Oct 2, 26
▲ Buy · 🎯$97
Price at call : $69.97 — upside +39%
Today : $68.86 — upside +41%
🎯 on INSP : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Oct 2, 27
matures : Oct 2, 27
RBC Capital ↗
Oct 1, 26
■ Sector Perform neutral · not a buy · 🎯$75
Price at call : $70.78 — gap to target +6%
Today : $68.86 — gap to target +9%
🎯 on INSP : no call matured yet · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Oct 1, 27
matures : Oct 1, 27
Freedom Capital Markets
Sep 21, 26
▲ Buy · 🎯$97
Price at call : $75.72 — upside +28%
Today : $68.86 — upside +41%
🎯 on INSP : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 21, 27
matures : Sep 21, 27
▲ Buy · 🎯$80
Price at call : $74.32 — upside +8%
Today : $68.86 — upside +16%
🎯 on INSP : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Sep 11, 27
matures : Sep 11, 27
■ Neutral neutral · not a buy · 🎯$60
Price at call : $60.09 — gap to target -0%
Today : $68.86 — gap to target -13%
🎯 on INSP : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
▲ Outperform · 🎯$65
Price at call : $60.09 — upside +8%
Today : $68.86 — upside -6%
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Oppenheimer ↗
Aug 4, 26
▲ Outperform · 🎯$85
Price at call : $60.09 — upside +41%
Today : $68.86 — upside +23%
🎯 on INSP : no call matured yet · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
See the other 80 calls, newest to oldest
Truist Securities ↗
Aug 4, 26
■ Hold neutral · not a buy · 🎯$62
Price at call : $60.09 — gap to target +3%
Today : $68.86 — gap to target -10%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Evercore ISI Group ↗
Aug 4, 26
■ In-Line neutral · not a buy · 🎯$54
Price at call : $64.14 — gap to target -16%
Today : $68.86 — gap to target -22%
🎯 on INSP : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Piper Sandler ↗
Aug 4, 26
■ Neutral neutral · not a buy · 🎯$60
Price at call : $64.14 — gap to target -6%
Today : $68.86 — gap to target -13%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
■ Neutral neutral · not a buy · 🎯$59
Price at call : $64.14 — gap to target -8%
Today : $68.86 — gap to target -14%
🎯 on INSP : no call matured yet · 📊 on Health : 38.1% · -2.9% (84 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Truist Securities ↗
Jul 16, 26
■ Hold neutral · not a buy · 🎯$54
Price at call : $50.6 — gap to target +7%
Today : $68.86 — gap to target -22%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
Freedom Capital Markets
Jul 1, 26
▲ Buy · 🎯$62
Price at call : $45.46 — upside +36%
Today : $68.86 — upside -10%
🎯 on INSP : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jul 1, 27
matures : Jul 1, 27
Evercore ISI Group ↗
Jun 23, 26
■ In-Line neutral · not a buy · 🎯$40
Price at call : $43.2 — gap to target -7%
Today : $68.86 — gap to target -42%
🎯 on INSP : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Jun 23, 27
matures : Jun 23, 27
Oppenheimer ↗
May 7, 26
■ Perform neutral · not a buy
🎯 on INSP : no call matured yet · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
■ Neutral neutral · not a buy · 🎯$54
Price at call : $45.7 — gap to target +18%
Today : $68.86 — gap to target -22%
🎯 on INSP : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Piper Sandler ↗
May 5, 26
■ Neutral neutral · not a buy · 🎯$55
Price at call : $45.7 — gap to target +20%
Today : $68.86 — gap to target -20%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
▲ Buy · 🎯$65
Price at call : $45.7 — upside +42%
Today : $68.86 — upside -6%
🎯 on INSP : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
RBC Capital ↗
May 5, 26
■ Sector Perform neutral · not a buy · 🎯$45
Price at call : $45.7 — gap to target -2%
Today : $68.86 — gap to target -35%
🎯 on INSP : no call matured yet · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Truist Securities ↗
May 5, 26
■ Hold neutral · not a buy · 🎯$50
Price at call : $45.7 — gap to target +9%
Today : $68.86 — gap to target -27%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Evercore ISI Group ↗
May 5, 26
▲ Outperform · 🎯$55
Price at call : $45.7 — upside +20%
Today : $68.86 — upside -20%
🎯 on INSP : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Wells Fargo ↗
May 5, 26
■ Equal-Weight neutral · not a buy · 🎯$56
Price at call : $45.7 — gap to target +23%
Today : $68.86 — gap to target -19%
🎯 on INSP : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
▲ Outperform · 🎯$55
Price at call : $48.25 — upside +14%
Today : $68.86 — upside -20%
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
■ Neutral neutral · not a buy · 🎯$50
Price at call : $48.25 — gap to target +4%
Today : $68.86 — gap to target -27%
🎯 on INSP : no call matured yet · 📊 on Health : 38.1% · -2.9% (84 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Truist Securities ↗
Apr 15, 26
■ Hold neutral · not a buy · 🎯$64
Price at call : $56.45 — gap to target +13%
Today : $68.86 — gap to target -7%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
▲ Outperform · 🎯$70
Price at call : $56.83 — upside +23%
Today : $68.86 — upside +2%
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
▲ Buy · 🎯$70
Price at call : $54.92 — upside +27%
Today : $68.86 — upside +2%
🎯 on INSP : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Apr 10, 27
matures : Apr 10, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$62
Price at call : $54.42 — upside +14%
Today : $68.86 — upside -10%
🎯 on INSP : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Buy · 🎯$85
Price at call : $62.46 — upside +36%
Today : $68.86 — upside +23%
🎯 on INSP : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
Wolfe Research ↗
Feb 13, 26
■ Peer Perform neutral · not a buy
🎯 on INSP : no call matured yet · 📊 overall : 34.9% · -2.8% (109 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
■ Hold neutral · not a buy · 🎯$66
Price at call : $59.76 — gap to target +10%
Today : $68.86 — gap to target -4%
🎯 on INSP : no call matured yet · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
RBC Capital ↗
Feb 12, 26
■ Sector Perform neutral · not a buy · 🎯$68
Price at call : $59.76 — gap to target +14%
Today : $68.86 — gap to target -1%
🎯 on INSP : no call matured yet · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
Piper Sandler ↗
Feb 12, 26
▲ Overweight · 🎯$85
Price at call : $59.65 — upside +42%
Today : $68.86 — upside +23%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
Truist Securities ↗
Feb 12, 26
■ Hold neutral · not a buy · 🎯$70
Price at call : $59.65 — gap to target +17%
Today : $68.86 — gap to target +2%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
▲ Outperform · 🎯$85
Price at call : $59.65 — upside +42%
Today : $68.86 — upside +23%
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
Wells Fargo ↗
Feb 12, 26
■ Equal-Weight neutral · not a buy · 🎯$70
Price at call : $59.65 — gap to target +17%
Today : $68.86 — gap to target +2%
🎯 on INSP : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
■ Neutral neutral · not a buy · 🎯$74
Price at call : $59.65 — gap to target +24%
Today : $68.86 — gap to target +7%
🎯 on INSP : no call matured yet · 📊 on Health : 38.1% · -2.9% (84 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
RBC Capital ↗
Jan 27, 26
■ Sector Perform neutral · not a buy · 🎯$90
Price at call : $81.79 — gap to target +10%
Today : $68.86 — gap to target +31%
🎯 on INSP : no call matured yet · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Jan 27, 27
matures : Jan 27, 27
Wells Fargo ↗
Jan 14, 26
▲ Overweight · 🎯$145
Price at call : $96.47 — upside +50%
Today : $68.86 — upside +111%
🎯 on INSP : no call matured yet · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Jan 14, 27
matures : Jan 14, 27
Truist Securities ↗
Jan 8, 26
▲ Buy · 🎯$120
Price at call : $98.38 — upside +22%
Today : $68.86 — upside +74%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
■ Neutral neutral · not a buy · 🎯$91
Price at call : $95.65 — gap to target -5%
Today : $68.86 — gap to target +32%
🎯 on INSP : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Dec 23, 26
matures : Dec 23, 26
RBC Capital ↗
Dec 17, 25
▲ Outperform · 🎯$175
Price at call : $118.27 — upside +48%
Today : $68.86 — upside +154%
🎯 on INSP : no call matured yet · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
▲ Outperform · 🎯$130
Price at call : $118.27 — upside +10%
Today : $68.86 — upside +89%
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
■ Neutral neutral · not a buy · 🎯$118
Price at call : $118.27 — gap to target -0%
Today : $68.86 — gap to target +71%
🎯 on INSP : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Dec 16, 26
matures : Dec 16, 26
Piper Sandler ↗
Dec 8, 25
▲ Overweight · 🎯$165
Price at call : $143.99 — upside +15%
Today : $68.86 — upside +140%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Dec 8, 26
matures : Dec 8, 26
Oppenheimer ↗
Dec 8, 25
▲ Outperform · 🎯$175
Price at call : $143.99 — upside +22%
Today : $68.86 — upside +154%
🎯 on INSP : no call matured yet · 📊 on Health : 47.4% · +5.9% (95 calls)
in progress (365j)
matures : Dec 8, 26
matures : Dec 8, 26
▲ Outperform · 🎯$180
Price at call : $140.03 — upside +29%
Today : $68.86 — upside +161%
🎯 on INSP : no call matured yet · 📊 on Health : 38.1% · -2.9% (84 calls)
in progress (365j)
matures : Dec 4, 26
matures : Dec 4, 26
Morgan Stanley ↗
Dec 2, 25
■ Equal-Weight neutral · not a buy · 🎯$130
Price at call : $134.75 — gap to target -4%
Today : $68.86 — gap to target +89%
🎯 on INSP : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
Truist Securities ↗
Nov 26, 25
▲ Buy · 🎯$165
Price at call : $127.33 — upside +30%
Today : $68.86 — upside +140%
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Nov 26, 26
matures : Nov 26, 26
Wolfe Research ↗
Nov 25, 25
▲ Outperform · 🎯$180
Price at call : $127.33 — upside +41%
Today : $68.86 — upside +161%
🎯 on INSP : no call matured yet · 📊 overall : 34.9% · -2.8% (109 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
Leerink Partners ↗
Aug 15, 25
■ Market Perform neutral · not a buy · 🎯$97
Price at call : $87.77 — gap to target +11%
Today : $68.86 — gap to target +41%
🎯 on INSP : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Aug 15, 26
matures : Aug 15, 26
Lake Street
Aug 5, 25
▲ Buy · 🎯$150
Price at call : $78.45 — upside +91%
Today : $68.86 — upside +118%
Expected +91% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 0% (1 call matured) · 📊 on Health : 53.8% · +14.6% (26 calls)
-24.9%
stock -25% · XLV +26%
matured Aug 5, 26
Leerink Partners ↗
Aug 5, 25
■ Market Perform neutral · not a buy · 🎯$116
Price at call : $87.91 — gap to target +32%
Today : $68.86 — gap to target +68%
🎯 on INSP : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Aug 5, 26
matures : Aug 5, 26
Piper Sandler ↗
Aug 5, 25
▲ Overweight · 🎯$150
Price at call : $87.91 — upside +71%
Today : $68.86 — upside +118%
Expected +71% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-31.6%
stock -32% · XLV +24%
matured Aug 5, 26
Leerink Partners ↗
Jul 14, 25
■ Market Perform neutral · not a buy · 🎯$149
Price at call : $130.26 — gap to target +14%
Today : $68.86 — gap to target +116%
🎯 on INSP : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Jul 14, 26
matures : Jul 14, 26
Leerink Partners ↗
May 5, 25
■ Market Perform neutral · not a buy · 🎯$176
Price at call : $158.74 — gap to target +11%
Today : $68.86 — gap to target +156%
🎯 on INSP : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : May 5, 26
matures : May 5, 26
Truist Securities ↗
Feb 11, 25
▲ Buy · 🎯$235
Price at call : $187.01 — upside +26%
Today : $68.86 — upside +241%
Expected +26% · Actual -68% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-68.1%
stock -68% · XLV +7%
matured Feb 11, 26
Piper Sandler ↗
Feb 10, 25
▲ Overweight · 🎯$233
Price at call : $180.99 — upside +29%
Today : $68.86 — upside +238%
Expected +29% · Actual -62% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-62.4%
stock -62% · XLV +6%
matured Feb 10, 26
Piper Sandler ↗
Nov 5, 24
▲ Overweight · 🎯$260
Price at call : $211.63 — upside +23%
Today : $68.86 — upside +278%
Expected +23% · Actual -60% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-60.4%
stock -60% · XLV -1%
matured Nov 5, 25
Truist Securities ↗
Sep 30, 24
▲ Buy · 🎯$240
Price at call : $209.36 — upside +15%
Today : $68.86 — upside +249%
Expected +15% · Actual -65% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-65.4%
stock -65% · XLV -6%
matured Sep 30, 25
Leerink Partners ↗
Sep 10, 24
■ Market Perform neutral · not a buy · 🎯$197
Price at call : $206.6 — gap to target -5%
Today : $68.86 — gap to target +186%
🎯 on INSP : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Sep 10, 25
matures : Sep 10, 25
Truist Securities ↗
Jul 16, 24
▲ Buy · 🎯$217
Price at call : $145.46 — upside +49%
Today : $68.86 — upside +215%
Expected +49% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-12.0%
stock -12% · XLV -12%
matured Jul 16, 25
Piper Sandler ↗
May 8, 24
▲ Overweight · 🎯$255
Price at call : $163.41 — upside +56%
Today : $68.86 — upside +270%
Expected +56% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-6.5%
stock -7% · XLV -6%
matured May 8, 25
▲ Buy · 🎯$250
Price at call : $214.79 — upside +16%
Today : $68.86 — upside +263%
Expected +16% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-26.8%
stock -27% · XLV -2%
matured Mar 27, 25
Truist Securities ↗
Mar 20, 24
▲ Buy · 🎯$280
Price at call : $195.23 — upside +43%
Today : $68.86 — upside +307%
Expected +43% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-15.5%
stock -16% · XLV +1%
matured Mar 20, 25
Truist Securities ↗
Feb 7, 24
▲ Buy · 🎯$280
Price at call : $202.01 — upside +39%
Today : $68.86 — upside +307%
Expected +39% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-9.8%
stock -10% · XLV +2%
matured Feb 6, 25
▲ Buy · 🎯$250
Price at call : $202.16 — upside +24%
Today : $68.86 — upside +263%
Expected +24% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-10.4%
stock -10% · XLV +2%
matured Feb 6, 25
Truist Securities ↗
Dec 22, 23
▲ Buy · 🎯$260
Price at call : $200.94 — upside +29%
Today : $68.86 — upside +278%
Expected +29% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-6.7%
stock -7% · XLV +3%
matured Dec 21, 24
▲ Buy · 🎯$215
Price at call : $126.9 — upside +69%
Today : $68.86 — upside +212%
Expected +69% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
+54.9%
stock +55% · XLV +20%
matured Nov 7, 24
Truist Securities ↗
Nov 8, 23
▲ Buy · 🎯$240
Price at call : $126.9 — upside +89%
Today : $68.86 — upside +249%
Expected +89% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+54.9%
stock +55% · XLV +20%
matured Nov 7, 24
Leerink Partners ↗
Oct 16, 23
■ Market Perform neutral · not a buy · 🎯$159
Price at call : $155.35 — gap to target +2%
Today : $68.86 — gap to target +131%
🎯 on INSP : no call matured yet · 📊 on Health : 54.5% · +7.0% (11 calls)
in progress (365j)
matures : Oct 15, 24
matures : Oct 15, 24
Truist Securities ↗
Oct 2, 23
▲ Buy · 🎯$340
Price at call : $182.44 — upside +86%
Today : $68.86 — upside +394%
Expected +86% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+16.3%
stock +16% · XLV +20%
matured Oct 1, 24
Truist Securities ↗
Aug 24, 23
▲ Buy · 🎯$340
Price at call : $215.53 — upside +58%
Today : $68.86 — upside +394%
Expected +58% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-12.4%
stock -12% · XLV +16%
matured Aug 23, 24
Truist Securities ↗
Aug 2, 23
▲ Buy · 🎯$363
Price at call : $284.23 — upside +28%
Today : $68.86 — upside +427%
Expected +28% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-47.4%
stock -47% · XLV +14%
matured Aug 1, 24
Truist Securities ↗
Jul 19, 23
▲ Buy · 🎯$380
Price at call : $318.13 — upside +19%
Today : $68.86 — upside +452%
Expected +19% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-54.8%
stock -55% · XLV +10%
matured Jul 18, 24
▲ Buy · 🎯$300
Price at call : $306.19 — upside -2%
Today : $68.86 — upside +336%
Expected -2% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-45.3%
stock -45% · XLV +11%
matured Jun 11, 24
Piper Sandler ↗
Jun 8, 23
▲ Overweight · 🎯$340
Price at call : $307 — upside +11%
Today : $68.86 — upside +394%
Expected +11% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-47.6%
stock -48% · XLV +13%
matured Jun 7, 24
Piper Sandler ↗
May 18, 23
▲ Overweight · 🎯$360
Price at call : $302.84 — upside +19%
Today : $68.86 — upside +423%
Expected +19% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-48.8%
stock -49% · XLV +12%
matured May 17, 24
Piper Sandler ↗
May 3, 23
▲ Overweight · 🎯$315
Price at call : $275.22 — upside +14%
Today : $68.86 — upside +357%
Expected +14% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-8.7%
stock -9% · XLV +5%
matured May 2, 24
▲ Buy · 🎯$300
Price at call : $261.26 — upside +15%
Today : $68.86 — upside +336%
Expected +15% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-14.6%
stock -15% · XLV +3%
matured Apr 13, 24
▲ Buy · 🎯$300
Price at call : $261.26 — upside +15%
Today : $68.86 — upside +336%
Expected +15% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (6 calls matureds) · 📊 on Health : 27.3% · -9.0% (88 calls)
-14.6%
stock -15% · XLV +3%
matured Apr 12, 24
Truist Securities ↗
Feb 8, 23
▲ Buy · 🎯$330
Price at call : $268.34 — upside +23%
Today : $68.86 — upside +379%
Expected +23% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-27.4%
stock -27% · XLV +10%
matured Feb 8, 24
Piper Sandler ↗
Feb 8, 23
▲ Overweight · 🎯$305
Price at call : $267.71 — upside +14%
Today : $68.86 — upside +343%
Expected +14% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-24.5%
stock -25% · XLV +9%
matured Feb 8, 24
Piper Sandler ↗
Jan 26, 23
▲ Overweight · 🎯$300
Price at call : $254.25 — upside +18%
Today : $68.86 — upside +336%
Expected +18% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-16.3%
stock -16% · XLV +4%
matured Jan 26, 24
Piper Sandler ↗
Aug 3, 22
▲ Overweight · 🎯$285
Price at call : $218.27 — upside +31%
Today : $68.86 — upside +314%
Expected +31% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+30.2%
stock +30% · XLV +1%
matured Aug 3, 23
Piper Sandler ↗
Nov 3, 21
▲ Overweight · 🎯$305
Price at call : $278.59 — upside +9%
Today : $68.86 — upside +343%
Expected +9% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-25.5%
stock -26% · XLV -3%
matured Nov 3, 22
Piper Sandler ↗
Aug 4, 21
▲ Overweight · 🎯$238
Price at call : $211 — upside +13%
Today : $68.86 — upside +246%
Expected +13% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on INSP : 17% (12 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+3.3%
stock +3% · XLV -2%
matured Aug 4, 22
Frequently asked questions
Should I buy Inspire Medical Systems, Inc. stock?
This isn't buy advice. For Inspire Medical Systems, Inc., the analyst consensus is "Hold", with an average price target of $63.50 (-8% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Inspire Medical Systems, Inc.). We show the numbers — you decide.
Is it too late to buy Inspire Medical Systems, Inc.? How high can it go?
The most bullish analyst target on Inspire Medical Systems, Inc. is $97.00 (+41% above today's price); the average is $63.50. That's the upside they see. Check how reliable those analysts have actually been on Inspire Medical Systems, Inc. on our site before trusting it.
Is Inspire Medical Systems, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Inspire Medical Systems, Inc., the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Will Inspire Medical Systems, Inc. stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will INSP stock recover (go back up)?
Should you invest in Inspire Medical Systems, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in INSP (and why hesitate).
What has Inspire Medical Systems, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: INSP performance & returns.
What is the best month to buy INSP?
The 12 months ranked by the stock's past returns: best & worst month to buy INSP.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX